Somatic mutation and selection at population scale
โApplying targeted NanoSeq to 1,042 non-invasive samples of oral epithelium and 371 blood samples from a twin cohort, we report an extremely rich selection landscape, with 46 genes under positive selection in oral epithelium, more than 62,000 driver mutations and evidence of negative selection in essential genes.โ
https://www.nature.com/articles/s41586-025-09584-w
Wafik S. El-Deiry, MD PhD FACP
Wafik S. El-Deiry, MD PhD FACP
weldeiry@med--mastodon-com.mostr.pub
npub10e9z...5hrr
Physician-Scientist; Translational-Oncologist; Director, Legorreta Cancer Center at Brown University. Pubs: http://tinyurl.com/s98xg3u #cancer #oncology Joined 11-5-2022
Give $50K to the homeless tipster because they deserve it.
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need


Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
/PRNewswire/ -- Caris Life Sciencesยฎ (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer,...
Dr. Deb Schrag Elected ASCO President for 2027-28 Term; Six New Members Elected to ASCO Board of Directors and Nominating Committee
https://www.asco.org/about-asco/press-center/news-releases/dr-deb-schrag-elected-asco-president-2027-28-term
Maybe AI would have done better here๐
Father of 2 Died from Sepsis After Waiting 34 Hours for Medication


People.com
Father of 2 Died from Sepsis After Waiting 34 Hours for Medication
A father of two died from sepsis after not being given the right medication for 34 hours in November 2022, a new investigation by the Parliamentary...
I was definitely not aware I am listed as Editor-in-Chief of the Asian Journal of Current Research in Clinical Cancer

Editorial Boards | Asian Journal of Current Research in Clinical Cancer - Galaxy Publication

FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews


U.S. Food and Drug Administration
FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews
FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews
Science will never be the same after it got to this point๐and the people making money out of this are not actually contributing to science. More like destruction of science in my opinion.
Harvard-affiliated Dana-Farber to pay $15 million to settle US claims over flawed studies
https://www.reuters.com/legal/litigation/harvard-affiliated-dana-farber-pay-15-million-settle-us-claims-over-flawed-2025-12-16/
Sholto David who is part of the inner circle of PubPeer gets $2.63 million out of this.
Harvard-affiliated Dana-Farber to pay $15 million to settle US claims over flawed studies โ Reuters
Dana-Farber Cancer Institute has agreed to pay $15 million to resolve claims that the Harvard Medical School affiliate wrongly used National Instit...
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma
https://www.nature.com/articles/s41467-025-66581-3